GABA launches first GT-002 clinical study; sleep patent filed
GABA launched its first clinical study for GT-002 and filed a new sleep treatment patent. Liquidity remains tight.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.